BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37652429)

  • 21. Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells.
    Valinezhad Sani F; Mosaffa F; Jamialahmadi K; Palizban A
    Nutr Cancer; 2020; 72(3):522-527. PubMed ID: 31290701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K/Akt/NF-κB signaling pathway.
    Muthusamy G; Gunaseelan S; Prasad NR
    J Nutr Biochem; 2019 Jan; 63():62-71. PubMed ID: 30342318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
    Wang Z; Zhou N; Zhao J; Zhang X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
    Han F; Liu G; Sun C; Wei J
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
    Jovelet C; Bénard J; Forestier F; Farinotti R; Bidart JM; Gil S
    Eur J Pharm Sci; 2012 Aug; 46(5):484-91. PubMed ID: 22484209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
    Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency.
    Lin R; Zhang L; Ye B; Wang Y; Li YD; Jason H; Liu W; Hu P; Chen J; Chen ZS; Chen Z
    Cancer Lett; 2023 Jun; 563():216181. PubMed ID: 37086953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells.
    Zhang Y; Qu X; Hu X; Yang X; Hou K; Teng Y; Zhang J; Sada K; Liu Y
    J Pathol; 2009 Jun; 218(2):248-55. PubMed ID: 19274672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cells.
    Song W; Jiang R; Zhao CM
    Asian Pac J Cancer Prev; 2012; 13(11):5619-25. PubMed ID: 23317227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity.
    Mollazadeh S; Sahebkar A; Kalalinia F; Behravan J; Hadizadeh F
    Bioorg Chem; 2019 Oct; 91():103156. PubMed ID: 31416030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
    Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP
    J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Polymersomes Co-Delivering Doxorubicin and Melittin to Overcome Multidrug Resistance.
    Han E; Kim D; Cho Y; Lee S; Kim J; Kim H
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death.
    Yu HG; Ai YW; Yu LL; Zhou XD; Liu J; Li JH; Xu XM; Liu S; Chen J; Liu F; Qi YL; Deng Q; Cao J; Liu SQ; Luo HS; Yu JP
    Int J Cancer; 2008 Jan; 122(2):433-43. PubMed ID: 17935137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.
    Jiang L; Zhang Y; Guo L; Liu C; Wang P; Ren W
    BMC Cancer; 2021 Dec; 21(1):1290. PubMed ID: 34856955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.
    Zhang L; Li Y; Hu C; Chen Y; Chen Z; Chen ZS; Zhang JY; Fang S
    Mol Cancer; 2022 Apr; 21(1):103. PubMed ID: 35459184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
    Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
    Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asiatic Acid (AA) Sensitizes Multidrug-Resistant Human Lung Adenocarcinoma A549/DDP Cells to Cisplatin (DDP) via Downregulation of P-Glycoprotein (MDR1) and Its Targets.
    Cheng Q; Liao M; Hu H; Li H; Wu L
    Cell Physiol Biochem; 2018; 47(1):279-292. PubMed ID: 29768255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.